Parexel, a provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health, from Clinical through Commercialization, has announced the opening of a new collaboration hub location within the Cambridge Innovation Center (CIC) in Cambridge, Mass. The new space will provide an ideal location for connection and collaboration with customers and employees working in Cambridge and Kendall Square.
“Cambridge is truly a hub for the life sciences industry,” said James Anthony, Senior Vice President and Global Head, Parexel Biotech. “With the continued growth of Parexel Biotech, we are seeing demand for our employees and customers to be in this area on a regular basis. The CIC presence provides us an opportunity to foster closer collaboration with our customers and provides our employees a convenient base of operations in this innovative and vibrant community.”
Parexel Biotech provides tailored solutions to the unique challenges faced by today’s biotech companies, from meeting clinical development timelines to optimizing product and pipeline value to navigating complex regulatory and reimbursement landscapes. The team provides life sciences companies strategic guidance based on years of industry experience combined with clinical and commercial services delivered through lean operational structures that are personalized to their needs and therapeutic specialty.
The Cambridge location will operate as a satellite location and will complement Parexel’s corporate headquarters, which is relocating to Newton, Mass. Earlier this month, Parexel convened the first meeting of its Patient Advisory Council, an initiative intended to drive innovation in drug development leveraging the patient perspective, in the Cambridge hub. Parexel announced the establishment of a second headquarters in its Durham, North Carolina location earlier this year.